Recent

% | $
Quotes you view appear here for quick access.

Ohr Pharmaceutical, Inc. Message Board

  • peendee peendee Nov 11, 2013 11:21 PM Flag

    How I Get OHRP to $1200 Per Share

    Livermore, the shots go for $1500 each plus doctor service fees. so if they do 6 per year, that's $12k per annum. I cant imagine ohrp would price the superior product at only $1k. I think it might be $300-400 per month, or roughly $4000-6000 per year. Even at $4k, 2 million patients in the developed world could afford the drug. That's $8 billion in revenues. In the developing world, lets say another $1-2 billion.

    So I can make a case for $10 billion in global revenues in a decade. since profit margins are so high, that might be $4 billion in profits after tax. So a 15 p/e on that profit is $60 billion. There are now 30 mm shares fully diluted. Lets say in 7-10 years the share count is 50 million. And $60 billion divided by 50 million is $1200 per share. That's even bigger than your price target I think.

    Now, if 3 million aged and diabetic people that have blindness can afford a few hundred dollars per month for vision and a better quality of life, we have a good chance at a blockbuster product. In fact, I chatted with a leading biotech newsletter writer who thinks $10 billion is a good estimate for a very efficacious drug. So my numbers may have a shot, and the stock target of $600 dollars might be a bit low....

    Strong buy? Ya think. Comments, observations. complaints requested.

    Like Livermore says, perform your own due diligence.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
OHRP
3.065-0.095(-3.01%)Jul 29 4:00 PMEDT